• Sign in
  • 1744009905_435.svg 1744009905_642.svg

  • Latest news
  • Top headlines
  • Most read
  • Columnists
O'zbekcha
Ўзбекча
Русский
  • O'zb
  • Ўзб
  • Рус
  • Eng
  • O'zb
  • Ўзб
  • Рус
  • Eng
  • Latest news
  • Top headlines
  • Most read
  • Columnists
    • USD12668.14
    • RUB161.15
    • EUR14640.57
    • Google play
    • App Store
    • Telegram
    • Tashkent
      +37°C
      • Andijan
      • Karshi
      • Bukhara
      • Samarkand
      • Ferghana
      • Sirdarya
      • Jizzakh
      • Termez
      • Namangan
      • Tashkent
      • Navoiy
      • Tashkent reg
      • Nukus
      • Urgench
    • Daryo
      • About Daryo
      • Editorial office
      • Contact us
      • Terms of use
      • Privacy policy
      • News archive
    • Advertisement
    • Social networks
      • Instagram | Main
      • Instagram | Lifestyle
      • Instagram | Sport
      • Facebook | Main
      • OK | Main
      • YouTube | Daryo
      • YouTube | Daryo in Russian
      • YouTube | Daryo Global
    Telegram Youtube Facebook Instagram Twitter vkontakte
    Daryo logo white
    • Uzbekistan
      • Others
      • Navoi
      • Tashkent region
      • Syrdarya
      • Jizzakh
      • Kashkadarya
      • Surkhandarya
      • Khorezm
      • Bukhara
      • Samarkand
      • Namangan
      • Fergana
      • Andijan
      • Karakalpakstan
      • Tashkent City
      • DaryoKindness
      • Weather
    • Central Asia
      • Uzbekistan
      • Afghanistan
      • Kyrgyzstan
      • Kazakhstan
      • Turkmenistan
      • Tajikistan
    • World
    • Money
      • Business
      • Economics
      • Finance
      • Crypto
    • Culture
      • Movies
      • Books
      • Music
      • Celebrities
    • Lifestyle
      • Women only
        • Children
        • Beauty
        • Carrier
        • Advises
        • Fashion
        • Recipes
      • Technology
        • Architecture
        • Gadjets
        • Science
        • Space
        • Media
      • Auto
      • Entertainment
      • Travel
      • Health
      • Education
        • Entrant
        • Learn english
    • Sport
      • Football
      • UFC
      • Boxing
    infinix
    Daryo.uz - Login
    Daryo.uz Daryo.uz
    Daryo.uz - Login
    Uzbekistan

    'Dok-1 Max' case update: Another official receives $45,000 for selling 3 indian medicines in Uzbekistan

    'Dok-1 Max' case update: Another official receives $45,000 for selling 3 indian medicines in Uzbekistan

    During the ongoing criminal case related to the "Dok-1 Max" syrup and its ointments, which are suspected to have caused the deaths of 65 children in Uzbekistan, new allegations of corruption have surfaced.

    'Dok-1 Max' case update: Another official receives $45,000 for selling 3 indian medicines in Uzbekistan
    Source: Daryo

    In the latest court session on October 20, a witness revealed that another Uzbek official demanded an additional $45,000 in addition to the standard registration fee for three Indian-manufactured medicines. This revelation was made by a correspondent from "Daryo" who was present in the courtroom.

    According to the witness, the money was handed over in installments – $20,000 twice and $25,000 once. In exchange, he received certificates for the medicines, and there were no discrepancies found in these certificates.

    Reportedly, the money was received by the head of the registration department at the State Center for the Examination and Standardization of Medicines, Medical Devices, and Medical Equipment, Sh.Sh. He denied these allegations, claiming that the witness was providing false information and denied ever receiving the money.

    Dok-1 Max update: Another official receives $45,000 for selling 3 indian medicines in Uzbekistan
    Source: Daryo

    In previous court sessions, it was alleged that the manufacturer of the "Dok-1 Max" syrup had offered a $33,000 bribe for the importation of the drug "Kuraraks" into Uzbekistan. C.R.P., the director of Kuramax Medical LLC, initially admitted to providing $33,000 to an individual named J.E. to halt an inspection at Marion Biotech Pvt.'s facility. However, he later recanted this statement, with J.E. confirming that the $33,000 had indeed been provided to him by the manufacturer's representative, and he subsequently delivered the money to Sh.Sh., the head of the registration department at the State Center for the Examination and Standardization of Medicines, Medical Devices, and Medical Equipment.

    During a court hearing on September 15, Sh.Sh. contradicted the claim that he had refused the $33,000, which he was told had been given to him. It had previously been reported that another Indian manufacturer had received an upfront payment of $50,000 and had demanded $88,000 for the re-registration of 11 medicines.

     

     

    Follow Daryo's official Instagram and Twitter pages to keep current on world news.

    21.10.2023, 00:59   Comments (0)   2096
    Facebook Twitter LinkedIn Telegram Email

    Comments (0)

    Sign in
    Leave A Reply Cancel

    On this topic

    Defendant in Dok-1 Max case asserts that he was pressured during investigation

    06.10.2023, 14:46

    Dok-1 Maks manufacturers request permission to sell remaining medicines in Uzbekistan 

    06.10.2023, 22:29

    Marion Biotech resumes production despite 65 child deaths as result of Dok-1 Maks in Uzbekistan

    11.10.2023, 19:22

    President Mirziyoyev addresses 2024 state budget 

    21.10.2023, 00:36

    President Mirziyoyev's address to OTS Security Council Secretaries

    20.10.2023, 14:36

    Uzbekistan addresses urgent water crisis with modernization initiatives

    20.10.2023, 14:28
    ×Lightbox Image

    Daryo.uz | Solution to your problems


    More than 500,000 new users: residents of Uzbekistan choose the Hambi superapp


    Beepul 's rising popularity: 3.5x user growth, transaction up 2.3x in 2024


    Don't want to waste time standing in lines? Pay your utility bills through the Ipoteka Retail mobile app?


    Beeline Uzbekistan started 2025 with a significant network modernization

     

    Recommended

    "Visa simplification with Uzbekistan could be on the table," EU Ambassador Klaar points out

    11 June, 12:12

    “Uzbekistan is undergoing large-scale reforms and transformation,” says EU business leader at TIIF

    11 June, 08:34

    Central Bank warns half of monthly income goes to loans as debt burden rises in Uzbekistan

    3 June, 12:34

    Uzbekistan’s foreign trade turnover reaches $24.6bn in 4M25, up 16.3% y/y

    22 May, 11:29
     
     
     

    Latest news

    EU to allocate €161mn in humanitarian aid for Afghanistan and regional refugees in 2025

    Afghanistan | 18 June, 15:30

    Russia to write off $300mn Tajikistan electricity debt

    World | 18 June, 14:01

    Central Asia–China Summit yields new agreements on trade, connectivity, and culture

    World | 18 June, 12:39

    Uzbekistan, China’s CAMCE sign agreement to jointly manage Yangi Avlod industrial zone

    Uzbekistan | 18 June, 11:34

    Uzbekistan donates 2,000 sets of school supplies to Ukrainian children

    Uzbekistan | 18 June, 10:30

    China to grant over $208mn to Central Asian countries in 2025

    Central Asia | 18 June, 09:01

    Central Asia–China trade turnover projected to reach $100bn in 2025

    Uzbekistan | 17 June, 19:50
    Daryo About Us

    Full reproduction or partial quoting of material, as well as the use of photographic, graphic, audio and/or video materials of Daryo (the Uzbek Press and Information Agency (UzAPI, now the Agency for Information and Mass Communications under the Presidential Administration of the Republic of Uzbekistan) is registered on 13.03.2015 with certificate number No. 0944 as a mass media) is allowed if there is a hyperlink to the website daryo.uz and/or are accompanied by a note indicating the authorship of the online publication Daryo. Individual publications may contain information that is not intended for users under the age of 18. Info@daryo.uz

    Telegram Youtube Facebook Instagram Twitter vkontakte

    © Simple Networking Solutions, 2013–2025

    Age restriction

    Did you find a bug? Press Ctrl + Enter

    • Terms of use
    • Privacy policy
    • Advertisement
    What are we going to search for?

    Sign In or Register

    Welcome Back!

    Login below or Register Now.

    Google

    or with email

    Leaving a comment, Пользовательского соглашения and Политики конфиденциальности

    Register Now

    Already registered? Login.

    Google

    or with email

    A password will be e-mailed to you.

    Leaving a comment, Пользовательского соглашения and Политики конфиденциальности

    Found an error in the text?

    ×

    Thank you. We have received your message and will fix the error as soon as possible.